Largest-ever study finds low complication rates in children who wear soft contact lenses
The largest-ever retrospective study of its kind has found very low complication rates in children who wear soft contact lenses, similar to rates in adults.
vision-research.eu - The Gateway to European Vision Research
You are here: vision-research.eu » News
News
Hydrogel could open new path for glaucoma treatment without drugs or surgery
Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery with a twice-a-year injection to control the buildup of pressure in the eye.
Researchers discover drug development target for retinal dystrophies
A team of LSU Health New Orleans researchers reports for the first time that deleting one of the inhibitors of the RPE65 gene in a mouse model that carries a human disease mutation prevents degeneration of cone photoreceptors that are used for daytime high-resolution color vision.
Sight restored by turning back the epigenetic clock
Neurons progressively deteriorate with age and lose resilience to injury. It emerges that treatment with three transcription factors can re-endow neurons in the mature eye with youthful characteristics and the capacity to regenerate.
Restoring a rudimentary form of vision in the blind
Restoration of vision in blind people through a brain implant is on the verge of becoming reality. Recent discoveries at the Netherlands Institute for Neuroscience (NIN) show that newly developed high-resolution implants in the visual cortex make it possible to recognize artificially induced shapes and percepts.
Global public health services fail to meet targets to reduce avoidable sight loss
A new global study has found no significant reduction in the number of people with treatable sight loss since 2010. Published in The Lancet Global Health, it examined population-based surveys of eye disease worldwide from 1980 and found public health services across the world are failing to meet targets to reduce avoidable sight loss.
Research reveals how COVID-19 affects the eyes
Sore eyes are the most significant vision-based indicator of COVID-19, according to new research published in the journal BMJ Open Ophthalmology.
The best science images of 2020
2020 has been a year like no other. The COVID-19 pandemic pushed science to the forefront and dominated lives. But the year also produced fresh images unrelated to the virus.
RetinAI collaborates with Novartis to provide AI solutions for ophthalmology projects
RetinAI Medical AG announces a multi-year collaboration with Novartis Pharma AG under which RetinAI’s IT solutions and artificial intelligence tools shall be employed to support multiple projects in ophthalmology and digital health. Both companies have previously worked successfully on pilot projects in this disease area.
Development of the first biohybrid artificial retina built with silk fibroin and retinal cells
An international research led by the Complutense University of Madrid has taken a further step to solve the age-related macular degeneration (AMD)-derived blidness problem with the development of the first biohybrid artificial retina built with silk fibroin and retinal cells.
Glaucoma Research Foundation going global
In light of the ongoing COVID-19 pandemic, the Glaucoma Research Foundation will host a virtual Glaucoma 360 annual meeting in 2021.
Researchers decry ‘pay to publish’ system — but don’t want it to stop
South African incentive programme has attracted criticism for encouraging unethical behaviour.
New insights about age-related macular degeneration could spur better treatments
"Wet" age-related macular degeneration (AMD) is one of the most common causes of irreversible vision loss in the elderly, and it occurs when abnormal and leaky blood vessels form in the retina, in part due to inflammation.
ARVO 2021 going fully virtual
The Association for Research in Vision and Ophthalmology announced the switch to a virtual format this week for its annual meeting, originally scheduled for May 2-6 in San Francisco.
The natural artistry of disease: A wintry landscape in the eye
Leukemias and lymphomas are life-threatening malignancies affecting white blood cells and the immune system; fortunately, radiotherapy and chemotherapy, combined with stem cell therapy, can improve survival significantly.
vision-research.eu is kindly supported by ROCHE
Home | Contact | Sitemap | Data protection declaration | Imprint | © 2021 European Vision Institute EEIG, Belgium | info@vision-research.eu